This is a match-making section for JPIAMR 14th call - Disrupting drug Resistance Using Innovative Design (DRUID).
Human Health
in silico, in vitro, in vivo
Host-targeted therapy; Respiratory epithelium; transcriptional profiling; viral/bacterial co-infections
Our expertise: respiratory virus/bacterial co-infections & superinfections. Our projects consist to identify novel antimicrobial therapies for mixed viral/bacterial infections of the respiratory tract using a combination of in silico and in vitro approaches, with a specific focus on different infection scenarios between respiratory viruses and multi-resistant bacteria. To mitigate the impact of antimicrobial multi-drug resistance, we propose using and implementing an innovative approach, which consist to target the host instead of the pathogens.
We offer our expertise to contribute to a project within the 14th JPIAMR Call, in the field of respiratory infections.
Submitted on 2022-01-12 11:54:31
« Return to the partner search tool